Gene Therapy Shows Signs of Delayed Progression in Fatal Neurodegenerative Disease

By News Health
20 minutes Ago

(MedPage Today) — A single intravenous infusion of adeno-associated virus serotype 9 encoding beta-galactosidase (AAV9-GLB1) was associated with short-lived adverse events, increased beta-galactosidase levels, and signs of delayed progression…

Source link : https://www.medpagetoday.com/neurology/generalneurology/119830

Author :

Publish date : 2026-02-10 21:58:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cancer in Canada: Progress Made, but Challenges Remain

Ozempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older Adults

AMA Joins Vaccine Review Effort as CDC Trust Plummets

FDA Drops Some REMS Requirements for Top Acne Medication

Prescribing Isotretinoin: FDA Approves iPLEDGE Modifications

Eye Bacteria Tied to Alzheimer's; Neurologist Pay Report; Parkinson's Brain Network